We've found
6,786
archived clinical trials in
Dermatology
We've found
6,786
archived clinical trials in
Dermatology
A Study of the Safety and Tolerability of MEDI-551 in Scleroderma
A Phase 1, Randomized, Double-blind, Placebo-controlled Study of the Safety and Tolerability of MEDI-551 in Scleroderma
Status: Archived
A Study of the Safety and Tolerability of MEDI-551 in Scleroderma
Updated: 1/1/1970
A Phase 1, Randomized, Double-blind, Placebo-controlled Study of the Safety and Tolerability of MEDI-551 in Scleroderma
Status: Archived
Updated: 1/1/1970
A Study of the Safety and Tolerability of MEDI-551 in Scleroderma
A Phase 1, Randomized, Double-blind, Placebo-controlled Study of the Safety and Tolerability of MEDI-551 in Scleroderma
Status: Archived
A Study of the Safety and Tolerability of MEDI-551 in Scleroderma
Updated: 1/1/1970
A Phase 1, Randomized, Double-blind, Placebo-controlled Study of the Safety and Tolerability of MEDI-551 in Scleroderma
Status: Archived
Updated: 1/1/1970
A Study of the Safety and Tolerability of MEDI-551 in Scleroderma
A Phase 1, Randomized, Double-blind, Placebo-controlled Study of the Safety and Tolerability of MEDI-551 in Scleroderma
Status: Archived
A Study of the Safety and Tolerability of MEDI-551 in Scleroderma
Updated: 1/1/1970
A Phase 1, Randomized, Double-blind, Placebo-controlled Study of the Safety and Tolerability of MEDI-551 in Scleroderma
Status: Archived
Updated: 1/1/1970
A Study of the Safety and Tolerability of MEDI-551 in Scleroderma
A Phase 1, Randomized, Double-blind, Placebo-controlled Study of the Safety and Tolerability of MEDI-551 in Scleroderma
Status: Archived
A Study of the Safety and Tolerability of MEDI-551 in Scleroderma
Updated: 1/1/1970
A Phase 1, Randomized, Double-blind, Placebo-controlled Study of the Safety and Tolerability of MEDI-551 in Scleroderma
Status: Archived
Updated: 1/1/1970
A Study of the Safety and Tolerability of MEDI-551 in Scleroderma
A Phase 1, Randomized, Double-blind, Placebo-controlled Study of the Safety and Tolerability of MEDI-551 in Scleroderma
Status: Archived
A Study of the Safety and Tolerability of MEDI-551 in Scleroderma
Updated: 1/1/1970
A Phase 1, Randomized, Double-blind, Placebo-controlled Study of the Safety and Tolerability of MEDI-551 in Scleroderma
Status: Archived
Updated: 1/1/1970
Observational Study to Assess Natural History in Cockayne Syndrome Patients
An Observational Study to Assess the Natural History Including Growth and Hearing in Patients With Cockayne Syndrome
Status: Archived
Observational Study to Assess Natural History in Cockayne Syndrome Patients
Updated: 1/1/1970
An Observational Study to Assess the Natural History Including Growth and Hearing in Patients With Cockayne Syndrome
Status: Archived
Updated: 1/1/1970
Observational Study to Assess Natural History in Cockayne Syndrome Patients
An Observational Study to Assess the Natural History Including Growth and Hearing in Patients With Cockayne Syndrome
Status: Archived
Observational Study to Assess Natural History in Cockayne Syndrome Patients
Updated: 1/1/1970
An Observational Study to Assess the Natural History Including Growth and Hearing in Patients With Cockayne Syndrome
Status: Archived
Updated: 1/1/1970
Comparison Between Asynchronous Online Care Model With Usual In Office Care for the Management of Atopic Dermatitis
Comparison Between Asynchronous Online Care Model for the Management of Atopic Dermatitis With That of Face-to-Face, Office Visits
Status: Archived
Comparison Between Asynchronous Online Care Model With Usual In Office Care for the Management of Atopic Dermatitis
Updated: 1/1/1970
Comparison Between Asynchronous Online Care Model for the Management of Atopic Dermatitis With That of Face-to-Face, Office Visits
Status: Archived
Updated: 1/1/1970
The Role of Topically Dissolved Oxygen (TDO) to Ameliorate Signs of Photodamage
The Role of Topically Dissolved Oxygen (TDO) to Ameliorate Signs of Photodamage in Individuals With Multiple Skin Conditions A Double-Blind, Placebo Controlled Comparative Trial
Status: Archived
The Role of Topically Dissolved Oxygen (TDO) to Ameliorate Signs of Photodamage
Updated: 1/1/1970
The Role of Topically Dissolved Oxygen (TDO) to Ameliorate Signs of Photodamage in Individuals With Multiple Skin Conditions A Double-Blind, Placebo Controlled Comparative Trial
Status: Archived
Updated: 1/1/1970
Genetic Screening for Filaggrin Mutation in Atopic Dermatitis and Ichthyosis Vulgaris in the African American Population
Genetic Screening for Filaggrin Mutation in Atopic Dermatitis and Ichthyosis Vulgaris in the African American Population
Status: Archived
Genetic Screening for Filaggrin Mutation in Atopic Dermatitis and Ichthyosis Vulgaris in the African American Population
Updated: 1/1/1970
Genetic Screening for Filaggrin Mutation in Atopic Dermatitis and Ichthyosis Vulgaris in the African American Population
Status: Archived
Updated: 1/1/1970
Genetic Screening for Filaggrin Mutation in Atopic Dermatitis and Ichthyosis Vulgaris in the African American Population
Genetic Screening for Filaggrin Mutation in Atopic Dermatitis and Ichthyosis Vulgaris in the African American Population
Status: Archived
Genetic Screening for Filaggrin Mutation in Atopic Dermatitis and Ichthyosis Vulgaris in the African American Population
Updated: 1/1/1970
Genetic Screening for Filaggrin Mutation in Atopic Dermatitis and Ichthyosis Vulgaris in the African American Population
Status: Archived
Updated: 1/1/1970
Safety and Efficacy Study of Altabax Ointment in the Treatment of Secondarily Infected Atopic Dermatitis
Use of Altabax Ointment (Retapamulin 1%) BID for 5 Days in Treatment of Secondary Infection With Staphylococcus Aureus (MRSA and MSSA) and Streptococcus Pyogenes in Atopic Dermatitis Patients - Open Label Pilot Study
Status: Archived
Safety and Efficacy Study of Altabax Ointment in the Treatment of Secondarily Infected Atopic Dermatitis
Updated: 1/1/1970
Use of Altabax Ointment (Retapamulin 1%) BID for 5 Days in Treatment of Secondary Infection With Staphylococcus Aureus (MRSA and MSSA) and Streptococcus Pyogenes in Atopic Dermatitis Patients - Open Label Pilot Study
Status: Archived
Updated: 1/1/1970
Acupressure in Pruritus for Atopic Dermatitis
Evaluating the Effectiveness of Acupressure in Relieving Pruritus Related to Atopic Dermatitis
Status: Archived
Acupressure in Pruritus for Atopic Dermatitis
Updated: 1/1/1970
Evaluating the Effectiveness of Acupressure in Relieving Pruritus Related to Atopic Dermatitis
Status: Archived
Updated: 1/1/1970
Finger Hardness Measure in Scleroderma
Durometer Skin Assessment in Scleroderma: a Study to Validate This New Tool in the Digital Tufts
Status: Archived
Finger Hardness Measure in Scleroderma
Updated: 1/1/1970
Durometer Skin Assessment in Scleroderma: a Study to Validate This New Tool in the Digital Tufts
Status: Archived
Updated: 1/1/1970
Epiduo Pediatric Acne Study
A Multi-center, Randomized, Vehicle-controlled, Double-blind, Study to Evaluate the Safety and Efficacy of Epiduo® (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% Administered Once Daily for the Treatment of Subjects 9 to 11 Years of Age With Acne Vulgaris
Status: Archived
Epiduo Pediatric Acne Study
Updated: 1/1/1970
A Multi-center, Randomized, Vehicle-controlled, Double-blind, Study to Evaluate the Safety and Efficacy of Epiduo® (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% Administered Once Daily for the Treatment of Subjects 9 to 11 Years of Age With Acne Vulgaris
Status: Archived
Updated: 1/1/1970
Epiduo Pediatric Acne Study
A Multi-center, Randomized, Vehicle-controlled, Double-blind, Study to Evaluate the Safety and Efficacy of Epiduo® (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% Administered Once Daily for the Treatment of Subjects 9 to 11 Years of Age With Acne Vulgaris
Status: Archived
Epiduo Pediatric Acne Study
Updated: 1/1/1970
A Multi-center, Randomized, Vehicle-controlled, Double-blind, Study to Evaluate the Safety and Efficacy of Epiduo® (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% Administered Once Daily for the Treatment of Subjects 9 to 11 Years of Age With Acne Vulgaris
Status: Archived
Updated: 1/1/1970
Epiduo Pediatric Acne Study
A Multi-center, Randomized, Vehicle-controlled, Double-blind, Study to Evaluate the Safety and Efficacy of Epiduo® (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% Administered Once Daily for the Treatment of Subjects 9 to 11 Years of Age With Acne Vulgaris
Status: Archived
Epiduo Pediatric Acne Study
Updated: 1/1/1970
A Multi-center, Randomized, Vehicle-controlled, Double-blind, Study to Evaluate the Safety and Efficacy of Epiduo® (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% Administered Once Daily for the Treatment of Subjects 9 to 11 Years of Age With Acne Vulgaris
Status: Archived
Updated: 1/1/1970
Epiduo Pediatric Acne Study
A Multi-center, Randomized, Vehicle-controlled, Double-blind, Study to Evaluate the Safety and Efficacy of Epiduo® (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% Administered Once Daily for the Treatment of Subjects 9 to 11 Years of Age With Acne Vulgaris
Status: Archived
Epiduo Pediatric Acne Study
Updated: 1/1/1970
A Multi-center, Randomized, Vehicle-controlled, Double-blind, Study to Evaluate the Safety and Efficacy of Epiduo® (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% Administered Once Daily for the Treatment of Subjects 9 to 11 Years of Age With Acne Vulgaris
Status: Archived
Updated: 1/1/1970
Epiduo Pediatric Acne Study
A Multi-center, Randomized, Vehicle-controlled, Double-blind, Study to Evaluate the Safety and Efficacy of Epiduo® (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% Administered Once Daily for the Treatment of Subjects 9 to 11 Years of Age With Acne Vulgaris
Status: Archived
Epiduo Pediatric Acne Study
Updated: 1/1/1970
A Multi-center, Randomized, Vehicle-controlled, Double-blind, Study to Evaluate the Safety and Efficacy of Epiduo® (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% Administered Once Daily for the Treatment of Subjects 9 to 11 Years of Age With Acne Vulgaris
Status: Archived
Updated: 1/1/1970
Epiduo Pediatric Acne Study
A Multi-center, Randomized, Vehicle-controlled, Double-blind, Study to Evaluate the Safety and Efficacy of Epiduo® (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% Administered Once Daily for the Treatment of Subjects 9 to 11 Years of Age With Acne Vulgaris
Status: Archived
Epiduo Pediatric Acne Study
Updated: 1/1/1970
A Multi-center, Randomized, Vehicle-controlled, Double-blind, Study to Evaluate the Safety and Efficacy of Epiduo® (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% Administered Once Daily for the Treatment of Subjects 9 to 11 Years of Age With Acne Vulgaris
Status: Archived
Updated: 1/1/1970
Epiduo Pediatric Acne Study
A Multi-center, Randomized, Vehicle-controlled, Double-blind, Study to Evaluate the Safety and Efficacy of Epiduo® (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% Administered Once Daily for the Treatment of Subjects 9 to 11 Years of Age With Acne Vulgaris
Status: Archived
Epiduo Pediatric Acne Study
Updated: 1/1/1970
A Multi-center, Randomized, Vehicle-controlled, Double-blind, Study to Evaluate the Safety and Efficacy of Epiduo® (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% Administered Once Daily for the Treatment of Subjects 9 to 11 Years of Age With Acne Vulgaris
Status: Archived
Updated: 1/1/1970
Epiduo Pediatric Acne Study
A Multi-center, Randomized, Vehicle-controlled, Double-blind, Study to Evaluate the Safety and Efficacy of Epiduo® (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% Administered Once Daily for the Treatment of Subjects 9 to 11 Years of Age With Acne Vulgaris
Status: Archived
Epiduo Pediatric Acne Study
Updated: 1/1/1970
A Multi-center, Randomized, Vehicle-controlled, Double-blind, Study to Evaluate the Safety and Efficacy of Epiduo® (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% Administered Once Daily for the Treatment of Subjects 9 to 11 Years of Age With Acne Vulgaris
Status: Archived
Updated: 1/1/1970
Epiduo Pediatric Acne Study
A Multi-center, Randomized, Vehicle-controlled, Double-blind, Study to Evaluate the Safety and Efficacy of Epiduo® (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% Administered Once Daily for the Treatment of Subjects 9 to 11 Years of Age With Acne Vulgaris
Status: Archived
Epiduo Pediatric Acne Study
Updated: 1/1/1970
A Multi-center, Randomized, Vehicle-controlled, Double-blind, Study to Evaluate the Safety and Efficacy of Epiduo® (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% Administered Once Daily for the Treatment of Subjects 9 to 11 Years of Age With Acne Vulgaris
Status: Archived
Updated: 1/1/1970
Epiduo Pediatric Acne Study
A Multi-center, Randomized, Vehicle-controlled, Double-blind, Study to Evaluate the Safety and Efficacy of Epiduo® (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% Administered Once Daily for the Treatment of Subjects 9 to 11 Years of Age With Acne Vulgaris
Status: Archived
Epiduo Pediatric Acne Study
Updated: 1/1/1970
A Multi-center, Randomized, Vehicle-controlled, Double-blind, Study to Evaluate the Safety and Efficacy of Epiduo® (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% Administered Once Daily for the Treatment of Subjects 9 to 11 Years of Age With Acne Vulgaris
Status: Archived
Updated: 1/1/1970
Epiduo Pediatric Acne Study
A Multi-center, Randomized, Vehicle-controlled, Double-blind, Study to Evaluate the Safety and Efficacy of Epiduo® (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% Administered Once Daily for the Treatment of Subjects 9 to 11 Years of Age With Acne Vulgaris
Status: Archived
Epiduo Pediatric Acne Study
Updated: 1/1/1970
A Multi-center, Randomized, Vehicle-controlled, Double-blind, Study to Evaluate the Safety and Efficacy of Epiduo® (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% Administered Once Daily for the Treatment of Subjects 9 to 11 Years of Age With Acne Vulgaris
Status: Archived
Updated: 1/1/1970
Epiduo Pediatric Acne Study
A Multi-center, Randomized, Vehicle-controlled, Double-blind, Study to Evaluate the Safety and Efficacy of Epiduo® (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% Administered Once Daily for the Treatment of Subjects 9 to 11 Years of Age With Acne Vulgaris
Status: Archived
Epiduo Pediatric Acne Study
Updated: 1/1/1970
A Multi-center, Randomized, Vehicle-controlled, Double-blind, Study to Evaluate the Safety and Efficacy of Epiduo® (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% Administered Once Daily for the Treatment of Subjects 9 to 11 Years of Age With Acne Vulgaris
Status: Archived
Updated: 1/1/1970
Epiduo Pediatric Acne Study
A Multi-center, Randomized, Vehicle-controlled, Double-blind, Study to Evaluate the Safety and Efficacy of Epiduo® (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% Administered Once Daily for the Treatment of Subjects 9 to 11 Years of Age With Acne Vulgaris
Status: Archived
Epiduo Pediatric Acne Study
Updated: 1/1/1970
A Multi-center, Randomized, Vehicle-controlled, Double-blind, Study to Evaluate the Safety and Efficacy of Epiduo® (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% Administered Once Daily for the Treatment of Subjects 9 to 11 Years of Age With Acne Vulgaris
Status: Archived
Updated: 1/1/1970
Epiduo Pediatric Acne Study
A Multi-center, Randomized, Vehicle-controlled, Double-blind, Study to Evaluate the Safety and Efficacy of Epiduo® (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% Administered Once Daily for the Treatment of Subjects 9 to 11 Years of Age With Acne Vulgaris
Status: Archived
Epiduo Pediatric Acne Study
Updated: 1/1/1970
A Multi-center, Randomized, Vehicle-controlled, Double-blind, Study to Evaluate the Safety and Efficacy of Epiduo® (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% Administered Once Daily for the Treatment of Subjects 9 to 11 Years of Age With Acne Vulgaris
Status: Archived
Updated: 1/1/1970
Epiduo Pediatric Acne Study
A Multi-center, Randomized, Vehicle-controlled, Double-blind, Study to Evaluate the Safety and Efficacy of Epiduo® (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% Administered Once Daily for the Treatment of Subjects 9 to 11 Years of Age With Acne Vulgaris
Status: Archived
Epiduo Pediatric Acne Study
Updated: 1/1/1970
A Multi-center, Randomized, Vehicle-controlled, Double-blind, Study to Evaluate the Safety and Efficacy of Epiduo® (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% Administered Once Daily for the Treatment of Subjects 9 to 11 Years of Age With Acne Vulgaris
Status: Archived
Updated: 1/1/1970
Epiduo Pediatric Acne Study
A Multi-center, Randomized, Vehicle-controlled, Double-blind, Study to Evaluate the Safety and Efficacy of Epiduo® (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% Administered Once Daily for the Treatment of Subjects 9 to 11 Years of Age With Acne Vulgaris
Status: Archived
Epiduo Pediatric Acne Study
Updated: 1/1/1970
A Multi-center, Randomized, Vehicle-controlled, Double-blind, Study to Evaluate the Safety and Efficacy of Epiduo® (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% Administered Once Daily for the Treatment of Subjects 9 to 11 Years of Age With Acne Vulgaris
Status: Archived
Updated: 1/1/1970
Epiduo Pediatric Acne Study
A Multi-center, Randomized, Vehicle-controlled, Double-blind, Study to Evaluate the Safety and Efficacy of Epiduo® (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% Administered Once Daily for the Treatment of Subjects 9 to 11 Years of Age With Acne Vulgaris
Status: Archived
Epiduo Pediatric Acne Study
Updated: 1/1/1970
A Multi-center, Randomized, Vehicle-controlled, Double-blind, Study to Evaluate the Safety and Efficacy of Epiduo® (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% Administered Once Daily for the Treatment of Subjects 9 to 11 Years of Age With Acne Vulgaris
Status: Archived
Updated: 1/1/1970
Epiduo Pediatric Acne Study
A Multi-center, Randomized, Vehicle-controlled, Double-blind, Study to Evaluate the Safety and Efficacy of Epiduo® (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% Administered Once Daily for the Treatment of Subjects 9 to 11 Years of Age With Acne Vulgaris
Status: Archived
Epiduo Pediatric Acne Study
Updated: 1/1/1970
A Multi-center, Randomized, Vehicle-controlled, Double-blind, Study to Evaluate the Safety and Efficacy of Epiduo® (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% Administered Once Daily for the Treatment of Subjects 9 to 11 Years of Age With Acne Vulgaris
Status: Archived
Updated: 1/1/1970
Epiduo Pediatric Acne Study
A Multi-center, Randomized, Vehicle-controlled, Double-blind, Study to Evaluate the Safety and Efficacy of Epiduo® (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% Administered Once Daily for the Treatment of Subjects 9 to 11 Years of Age With Acne Vulgaris
Status: Archived
Epiduo Pediatric Acne Study
Updated: 1/1/1970
A Multi-center, Randomized, Vehicle-controlled, Double-blind, Study to Evaluate the Safety and Efficacy of Epiduo® (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% Administered Once Daily for the Treatment of Subjects 9 to 11 Years of Age With Acne Vulgaris
Status: Archived
Updated: 1/1/1970
Epiduo Pediatric Acne Study
A Multi-center, Randomized, Vehicle-controlled, Double-blind, Study to Evaluate the Safety and Efficacy of Epiduo® (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% Administered Once Daily for the Treatment of Subjects 9 to 11 Years of Age With Acne Vulgaris
Status: Archived
Epiduo Pediatric Acne Study
Updated: 1/1/1970
A Multi-center, Randomized, Vehicle-controlled, Double-blind, Study to Evaluate the Safety and Efficacy of Epiduo® (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% Administered Once Daily for the Treatment of Subjects 9 to 11 Years of Age With Acne Vulgaris
Status: Archived
Updated: 1/1/1970
Pharmacokinetics and Safety Study of Single and Multiple Oral Doses Prodarsanâ„¢ in Patients With Cockayne Syndrome
A Phase I/II Crossover Study To Evaluate and Compare the Pharmacokinetics of a Single IV Dose of D-Mannitol (Osmitrol®10%) to Single and Multiple, Escalating Doses of Liquid, Oral Prodarsan™ in Patients With Cockayne Syndrome
Status: Archived
Pharmacokinetics and Safety Study of Single and Multiple Oral Doses Prodarsanâ„¢ in Patients With Cockayne Syndrome
Updated: 1/1/1970
A Phase I/II Crossover Study To Evaluate and Compare the Pharmacokinetics of a Single IV Dose of D-Mannitol (Osmitrol®10%) to Single and Multiple, Escalating Doses of Liquid, Oral Prodarsan™ in Patients With Cockayne Syndrome
Status: Archived
Updated: 1/1/1970
Feasibility Study of Barrier Enhancement for Eczema Prevention
Feasibility Study of Barrier Enhancement for Eczema Prevention (BEEP)
Status: Archived
Feasibility Study of Barrier Enhancement for Eczema Prevention
Updated: 1/1/1970
Feasibility Study of Barrier Enhancement for Eczema Prevention (BEEP)
Status: Archived
Updated: 1/1/1970
Study to Evaluate the Effect of a Nu Skin Product and Device for Brown Spots
A Single Blind, Placebo Controlled Trial to Evaluate Effects of a Study Medication, a Nu Skin Lightening Product With and Without Iontophoresis vs Tretinoin Cream vs Vehicle Control for Facial Hyperpigmentation
Status: Archived
Study to Evaluate the Effect of a Nu Skin Product and Device for Brown Spots
Updated: 1/1/1970
A Single Blind, Placebo Controlled Trial to Evaluate Effects of a Study Medication, a Nu Skin Lightening Product With and Without Iontophoresis vs Tretinoin Cream vs Vehicle Control for Facial Hyperpigmentation
Status: Archived
Updated: 1/1/1970
Assessing and Improving Patient Knowledge About Keloid Scars (Keloids)
Assessing and Improving Patient Knowledge About Keloids
Status: Archived
Assessing and Improving Patient Knowledge About Keloid Scars (Keloids)
Updated: 1/1/1970
Assessing and Improving Patient Knowledge About Keloids
Status: Archived
Updated: 1/1/1970
Safety Study of the VEGA UV-A System to Treat Keratoconus
Safety and Effectiveness of the VEGA UV-A System for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Status: Archived
Safety Study of the VEGA UV-A System to Treat Keratoconus
Updated: 1/1/1970
Safety and Effectiveness of the VEGA UV-A System for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Status: Archived
Updated: 1/1/1970
Safety Study of the VEGA UV-A System to Treat Keratoconus
Safety and Effectiveness of the VEGA UV-A System for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Status: Archived
Safety Study of the VEGA UV-A System to Treat Keratoconus
Updated: 1/1/1970
Safety and Effectiveness of the VEGA UV-A System for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Status: Archived
Updated: 1/1/1970
Safety Study of the VEGA UV-A System to Treat Keratoconus
Safety and Effectiveness of the VEGA UV-A System for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Status: Archived
Safety Study of the VEGA UV-A System to Treat Keratoconus
Updated: 1/1/1970
Safety and Effectiveness of the VEGA UV-A System for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Status: Archived
Updated: 1/1/1970
Safety Study of the VEGA UV-A System to Treat Keratoconus
Safety and Effectiveness of the VEGA UV-A System for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Status: Archived
Safety Study of the VEGA UV-A System to Treat Keratoconus
Updated: 1/1/1970
Safety and Effectiveness of the VEGA UV-A System for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Status: Archived
Updated: 1/1/1970
Safety Study of the VEGA UV-A System to Treat Keratoconus
Safety and Effectiveness of the VEGA UV-A System for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Status: Archived
Safety Study of the VEGA UV-A System to Treat Keratoconus
Updated: 1/1/1970
Safety and Effectiveness of the VEGA UV-A System for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Status: Archived
Updated: 1/1/1970
Safety Study of the VEGA UV-A System to Treat Keratoconus
Safety and Effectiveness of the VEGA UV-A System for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Status: Archived
Safety Study of the VEGA UV-A System to Treat Keratoconus
Updated: 1/1/1970
Safety and Effectiveness of the VEGA UV-A System for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Status: Archived
Updated: 1/1/1970
Safety Study of the VEGA UV-A System to Treat Keratoconus
Safety and Effectiveness of the VEGA UV-A System for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Status: Archived
Safety Study of the VEGA UV-A System to Treat Keratoconus
Updated: 1/1/1970
Safety and Effectiveness of the VEGA UV-A System for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Status: Archived
Updated: 1/1/1970
Safety Study of the VEGA UV-A System to Treat Keratoconus
Safety and Effectiveness of the VEGA UV-A System for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Status: Archived
Safety Study of the VEGA UV-A System to Treat Keratoconus
Updated: 1/1/1970
Safety and Effectiveness of the VEGA UV-A System for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Status: Archived
Updated: 1/1/1970
Safety Study of the VEGA UV-A System to Treat Keratoconus
Safety and Effectiveness of the VEGA UV-A System for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Status: Archived
Safety Study of the VEGA UV-A System to Treat Keratoconus
Updated: 1/1/1970
Safety and Effectiveness of the VEGA UV-A System for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Status: Archived
Updated: 1/1/1970
A Dose-Ranging Study Evaluating the Safety and Efficacy of IDP-107 in Patients With Acne Vulgaris
Status: Archived
A Dose-Ranging Study Evaluating the Safety and Efficacy of IDP-107 in Patients With Acne Vulgaris
Status: Archived
Updated: 1/1/1970
Updated: 1/1/1970
A Dose-Ranging Study Evaluating the Safety and Efficacy of IDP-107 in Patients With Acne Vulgaris
Status: Archived
A Dose-Ranging Study Evaluating the Safety and Efficacy of IDP-107 in Patients With Acne Vulgaris
Status: Archived
Updated: 1/1/1970
Updated: 1/1/1970
A Dose-Ranging Study Evaluating the Safety and Efficacy of IDP-107 in Patients With Acne Vulgaris
Status: Archived
A Dose-Ranging Study Evaluating the Safety and Efficacy of IDP-107 in Patients With Acne Vulgaris
Status: Archived
Updated: 1/1/1970
Updated: 1/1/1970